Your browser doesn't support javascript.
loading
Molecular Epidemiology and Treatment Patterns of Patients With EGFR Exon 20-Mutant NSCLC in the Precision Oncology Era: The European EXOTIC Registry.
Mountzios, Giannis; Planchard, David; Metro, Giulio; Tsiouda, Dora; Prelaj, Arsela; Lampaki, Sofia; Shalata, Walid; Riudavets, Mariona; Christopoulos, Petros; Girard, Nicolas; Albarrán-Artahona, Víctor; Garcia Campelo, Rosario; Samitas, Konstantinos; Banna, Giuseppe Luigi; Boukovinas, Ioannis; Agbarya, Abed; Koumarianou, Anna; Perdikouri, Eleni-Isidora; Kosmidis, Paris; Linardou, Helena; Mauri, David; Mavroudis, Dimitrios; Athanasiadis, Ilias; Kalofonos, Haralambos; Xenidis, Nikolaos; Korantzis, Ippokratis; Ardavanis, Alexandros; Rallis, Grigorios; Bottiglieri, Achille; Efthymiadis, Konstantinos; Oikonomopoulos, Georgios; Kokkalis, Alexandros; Saloustros, Emmanouil; Tsoukalas, Nikolaos; Bartzi, Dimitra; Economopoulou, Panagiota; Psyrri, Amanda; Reck, Martin; Lo Russo, Giuseppe.
Afiliación
  • Mountzios G; Fourth Oncology Department and Clinical Trials Unit, Henry Dunant Hospital Center, Athens, Greece.
  • Planchard D; Thoracic Group, Department of Medical Oncology, Institut Gustave-Roussy, Villejuif, France.
  • Metro G; Medical Oncology, Santa Maria della Misericordia Hospital, Azienda Ospedaliera di Perugia, Perugia, Italy.
  • Tsiouda D; Department of Thoracic Oncology, Theageneion Hospital, Thessaloniki, Greece.
  • Prelaj A; Thoracic Oncology Unit, Medical Oncology Department 1, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
  • Lampaki S; Department of Electronics, Information, and Bioengineering, Politecnico di Milano, Milan, Italy.
  • Shalata W; Department of Pneumonology, "Papanikolaou" Hospital, Thessaloniki, Greece.
  • Riudavets M; The Legacy Heritage Center & Dr. Larry Norton Institute, Soroka Medical Center and Ben-Gurion University of the Negev, Beer Sheva, Israel.
  • Christopoulos P; Thoracic Group, Department of Medical Oncology, Institut Gustave-Roussy, Villejuif, France.
  • Girard N; Department of Thoracic Oncology, Thoraxklinik at Heidelberg University Hospital and German Center for Lung Research (DZL), Heidelberg, Germany.
  • Albarrán-Artahona V; Thorax Institute, Institut Curie, Paris, France and UVSQ, Paris-Saclay University, Versailles, France.
  • Garcia Campelo R; Thoracic Oncology Group, Medical Oncology Department, Hospital Clinic, Barcelona, Spain.
  • Samitas K; Medical Oncology Department, Thoracic Tumors Unit, University Hospital A Coruña and Biomedical Research Institute (INIBIC, A Coruña), Coruña, Spain.
  • Banna GL; 7th Department of Pneumonology, Sotiria Thoracic Hospital, Athens, Greece.
  • Boukovinas I; Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Turin, Italy.
  • Agbarya A; Department of Medical Oncology, Bioclinic Hospital, Thessaloniki, Greece.
  • Koumarianou A; Institute of Oncology, Bnai Zion Medical Center, Haifa, Israel.
  • Perdikouri EI; Department of Medical Oncology, Attikon University Hospital, Athens, Greece.
  • Kosmidis P; Department of Medical Oncology, Hospital of Volos, Volos, Greece.
  • Linardou H; Second Department of Medical Oncology, Hygeia Hospital, Athens, Greece.
  • Mauri D; Fourth Oncology Department, Metropolitan Hospital, Athens, Greece.
  • Mavroudis D; Department of Medical Oncology, University Hospital of Ioannina, Ioannina, Greece.
  • Athanasiadis I; Department of Medical Oncology, University Hospital of Herakleion, Herakleion, Greece.
  • Kalofonos H; Department of Medical Oncology, "MITERA" Hospital, Athens, Greece.
  • Xenidis N; Department of Medical Oncology, University Hospital of Patras, Patras, Greece.
  • Korantzis I; Department of Medical Oncology, University Hospital of Alexandroupolis, Alexandroupolis, Greece.
  • Ardavanis A; Department of Medical Oncology, "Saint Loukas" Hospital, Thessaloniki, Greece.
  • Rallis G; First Department of Medical Oncology, "Saint Savvas" Hospital, Athens, Greece.
  • Bottiglieri A; Department of Medical Oncology, "Theageneion Hospital," Thessaloniki, Greece.
  • Efthymiadis K; Thoracic Oncology Unit, Medical Oncology Department 1, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
  • Oikonomopoulos G; Department of Electronics, Information, and Bioengineering, Politecnico di Milano, Milan, Italy.
  • Kokkalis A; Department of Medical Oncology, University Hospital "Papageorgiou," Thessaloniki, Greece.
  • Saloustros E; Second Oncology Department, Metropolitan Hospital, Athens, Greece.
  • Tsoukalas N; Department of Medical Oncology, University Hospital of Larisa, Larisa, Greece.
  • Bartzi D; Department of Medical Oncology, University Hospital of Larisa, Larisa, Greece.
  • Economopoulou P; Department of Medical Oncology, 401 General Military Hospital, Athens, Greece.
  • Psyrri A; Department of Medical Oncology, 251 General Airforce Hospital, Athens, Greece.
  • Reck M; Department of Medical Oncology, 2nd Department of Internal Medicine, Attikon University Hospital, Athens, Greece.
  • Lo Russo G; Department of Medical Oncology, 2nd Department of Internal Medicine, Attikon University Hospital, Athens, Greece.
JTO Clin Res Rep ; 4(1): 100433, 2023 Jan.
Article en En | MEDLINE | ID: mdl-36793384
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Prognostic_studies / Screening_studies Idioma: En Revista: JTO Clin Res Rep Año: 2023 Tipo del documento: Article País de afiliación: Grecia
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Prognostic_studies / Screening_studies Idioma: En Revista: JTO Clin Res Rep Año: 2023 Tipo del documento: Article País de afiliación: Grecia